Skip to main content

Table 4 Medication pathway of antidepressants for the MDS group in each regimen

From: Real-world evidence from a retrospective study on suicide during depression: clinical characteristics, treatment patterns and disease burden

Switch

Top5

1st regimen

 

Medication

n(%)

 

0 time

(n = 2661)

1

SSRI + AP

730 (27.43)

 

2

SSRI

643 (24.16)

 

3

SNRI + AP

273 (10.26)

 

4

SNRI

178 (6.69)

2nd regimen

 

5

SSRI + AP + MS

106 (3.98)

Medication

n(%)

 

1 time

(n = 850)

1

SSRI

177 (20.82)

SSRI + AP

111 (62.71)

 
   

SSRI + MS

23 (12.99)

 
   

SSRI + NaSSA

19 (10.73)

 

2

SSRI + AP

128 (15.06)

SSRI + AP + MS

44 (34.38)

 
   

SSRI

22 (17.19)

 
   

AP

15 (11.72)

 

3

AP

66 (7.76)

SSRI + AP

27 (40.91)

 
   

AP + MS

24 (36.36)

 
   

SNRI + AP

9 (13.64)

 

4

SNRI

58 (6.82)

SNRI + AP

37 (63.79)

 
   

NaSSA + SNRI

8 (13.79)

 
   

SNRI + MS

3 (5.17)

 

5

SNRI + AP

45 (5.29)

SNRI

10 (22.22)

 
   

NaSSA + SNRI + AP

9 (20.00)

3rd regimen

   

SNRI + other + AP

7 (15.56)

Medication

n(%)

2 times

(n = 405)

1

SSRI + AP

86 (21.23)

SSRI + SNRI + AP

21 (24.42)

SNRI + AP

20 (95.24)

   

SSRI + AP + MS

20 (23.26)

AP + MS

13 (65.00)

   

SSRI + SSRI + AP

16 (18.60)

SSRI + AP

15 (93.75)

2

SSRI

71 (17.53)

SSRI + SNRI

17 (23.94)

SNRI

15 (88.24)

   

SSRI + AP

14 (19.72)

SSRI + AP + MS

6 (42.86)

     

SNRI + AP

3 (21.43)

   

SSRI + SSRI

11 (15.49)

SSRI

9 (81.82)

3

SSRI + NaSSA

30 (7.41)

SSRI + NaSSA + AP

7 (23.33)

SSRI + AP

3 (42.86)

   

SSRI + NaSSA + SNRI

6 (20.00)

NaSSA + SNRI

4 (66.67)

4

SNRI + AP

26 (6.42)

SSRI + SNRI + AP

8 (30.77)

SSRI + AP

6 (75.00)

   

SNRI + AP + MS

6 (23.08)

AP + MS

4 (66.67)

5

SNRI

22 (5.43)

SNRI + AP

7 (31.82)

SSRI + SNRI + AP

1 (14.29)

     

SSRI + AP + MS

1 (14.29)

   

SSRI + SNRI

5 (22.73)

SSRI

3 (60.00)

5

NaSSA

22 (5.43)

SSRI + NaSSA

9 (40.91)

SSRI

7 (77.78)

   

NaSSA + SNRI

6 (27.27)

SNRI

3 (50.00)

  1. Abbreviations: AD, antidepressants; AP, antipsychotics;MS, mood stabilizers; SSRI, Selective Serotonin Reuptake Inhibitors; SNRI, Serotonin-Norepinephrine Reuptake Inhibitor; NDRI, Norepinephrine Dopamine Reuptake Inhibitor